Tilray Urging Shareholders To Support Dilution, Proxy Advisory Firm Joins The Plea Ahead Of Upcoming Shareholders Meeting
Canadian cannabis giant Tilray, Inc. (NASDAQ: TLRY) confirmed Wednesday that another independent proxy advisory firm is recommending that shareholders back all the company’s proposals at a special meeting scheduled for July 29.
